CD8A and neoplasm: By Immunohistochemical staining, both the number of tumor-infiltrating CD3+ and CD8 + T cells were notably increased after the combination treatment by MMC and PD-L1 antibody than the two individual monotherapies alone (Fig. 3a, b).